Thymol Impacts the Progression of Endometriosis by Disrupting Estrogen Signaling Pathways and Inflammatory Responses
Yu Zhang, Aftab Shaukat, Han Zhang, Yao-Feng Yang, Hui-Xia Li, Guang-Ya Li, Ying-Nan Liu, Chen Liang, Jin-Wen Kang, Shao-Chuan Li, Ren-Wei Su · 2024
Read Thymol Impacts the Progression of Endometriosis by Disrupting Estrogen Signaling Pathways and Inflammatory Responses by Yu Zhang, Aftab Shaukat, Han Zhang, Yao-Feng Yang, Hui-Xia Li, Guang-Ya Li, Ying-Nan Liu, Chen Liang, Jin-Wen Kang, Shao-Chuan Li, Ren-Wei Su (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642495.txt.
Description
Yu Zhang and co-authors test thymol, a scent compound from thyme, against endometriosis in mice and cells, in work from 2024. In this disease, womb lining tissue grows where it should not, which brings pain and loss of fertility. The state feeds on estrogen and on long-term swelling in the tissue.
Mice with the disease got one of two thymol doses by mouth for three weeks. Treated mice had smaller, lighter stray tissue, with fewer growth cells and more cell death. Key swelling signals fell, and the estrogen path was damped while its partner path rose. Cell tests in the lab matched that shift. The normal womb lining looked unharmed, and the team notes the drug left the base for pregnancy intact. More work is needed before use in women.
Catalog record
| CREATOR | Yu Zhang, Aftab Shaukat, Han Zhang, Yao-Feng Yang, Hui-Xia Li, Guang-Ya Li, Ying-Nan Liu, Chen Liang, Jin-Wen Kang, Shao-Chuan Li, Ren-Wei Su |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |